| ALPCX | FFFMX | ALPCX / FFFMX | |
| Total Expense Ratio | 1.84 | 0.32 | 575% |
| Annual Report Gross Expense Ratio | 1.84 | 0.32 | 575% |
| Fund Existence | 25 years | 6 years | - |
| Gain YTD | 6.895 | 6.672 | 103% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.9B | 117B | 2% |
| Annual Yield % from dividends | 0.50 | 1.70 | 29% |
| Returns for 1 year | 7.80 | 9.94 | 78% |
| Returns for 3 years | 16.41 | 37.43 | 44% |
| Returns for 5 years | -5.02 | 39.91 | -13% |
| Returns for 10 years | 39.72 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PPH | 103.47 | 0.94 | +0.92% |
| VanEck Pharmaceutical ETF | |||
| EMXF | 59.82 | 0.44 | +0.75% |
| iShares ESG Advanced MSCI EM ETF | |||
| XLKI | 27.63 | 0.10 | +0.35% |
| State Street®TechSelSectSPDR®PrmETF | |||
| RSP | 209.61 | 0.46 | +0.22% |
| Invesco S&P 500® Equal Weight ETF | |||
| RNEM | 55.89 | N/A | N/A |
| First Trust Emerging Markets Eq Sel ETF | |||